Please provide your email address to receive an email when new articles are posted on . The type of arteriovenous access placement, graft or fistula, used first in older patients receiving ...
In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...
The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...
– ATEV™ demonstrated superiority at six and 12 months (co-primary endpoints) compared to autogenous fistula, the current standard of care for hemodialysis access – - ATEV also showed superior function ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Market Report for AV Fistula Needles 2017 - MedCore" report to their offering. An AV fistula needle enables access ...
- The ATEV™ was observed to have superior duration of use over 24 months compared to autogenous fistula in high-need subgroups with historically poor outcomes with AV fistula procedures - - The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback